11ß-HSD1 and Metabolic Syndrome
NCT00370305
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Metabolic Syndrome
Impaired Glucose Tolerance
Interventions
DRUG:
rosiglitazone
Sponsor
Charite University, Berlin, Germany